References
Aarestrup J, Kitahara CM, Baker JL (2019) Birthweight and risk of thyroid cancer and its histological types: a large cohort study. Cancer Epidemiol 62:101564
Li Q, Zhang S, Wang M, Dong S, Wang Y, Liu S, Lu T, Fu Y, Wang X, Chen G (2019) Downregulated miR-21 mediates matrine-induced apoptosis via the PTEN/Akt signaling pathway in FTC-133 human follicular thyroid cancer cells. Oncol Lett 18(4):3553–3560
Feng YH, Tsao CJ (2016) Emerging role of microRNA-21 in cancer. Biomed Rep 5(4):395–402
Werner TA, Dizdar L, Nolten I, Riemer JC, Mersch S, Schütte SC, Driemel C, Verde PE, Raba K, Topp SA, Schott M, Knoefel WT, Krieg A (2017) Survivin and XIAP—two potential biological targets in follicular thyroid carcinoma. Sci Rep 7(1):11383
Gulten T, Yakut T, Karkucak M, Baytan B, Guneş AM (2009) AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia. J Clin Lab Anal 23(6):368–371
Ahmed AA, Essa MEA (2019) Potential of epigenetic events in human thyroid cancer. Cancer Genet 239:13–21
Zhang JT, Cai QY, Ji SS, Zhang HX, Wang YH, Yan HT, Yang XJ (2016) Decreased miR-143 and increased miR-21 placental expression levels are associated with macrosomia. Mol Med Rep 13(4):3273–3280
Lin XH, Wu DD, Gao L, Zhang JY, Pan HT, Wang H, Li C, Zhang P, Guo MX, Wu YT, Tan YJ, Jin L, Xiang YQ, Li JX, Sheng JZ, Huang HF (2016) Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children. Oncotarget 7(52):86511–86521
Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR (2019) DNA methylation-based method to differentiate malignant from benign thyroid lesions. Thyroid 29(9):1244–1254
Haertle L, El Hajj N, Dittrich M, Müller T, Nanda I, Lehnen H, Haaf T (2017) Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. Clin Epigenetics 9:28
Malamitsi-Puchner A, Baka S, Boutsikou M, Liosi S, Gourgiotis D, Protonotariou E, Hassiakos D, Briana DD (2009) Cord blood survivin concentrations in human full-term normal and complicated pregnancies. In Vivo 23(1):139–142
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mormile, R. Birth weight and risk of thyroid cancer in later life: the fetal reprogramming of miR-21 and survivin gene expression?. Arch Gynecol Obstet 301, 867–868 (2020). https://doi.org/10.1007/s00404-020-05484-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05484-8